India’s chemotherapy market, valued at USD 5.14 Billion in 2024, is on track to hit USD 16.13 Billion by 2033, with a projected CAGR of 12.54%. The market's expansion is supported by factors such as a growing cancer burden, improved drug affordability, diagnostic innovation, heightened early detection efforts, and a shift toward combination and precision therapies. https://www.imarcgroup.com/india-chemotherapy-market